hMG-IBSA vs Menopur in IVF (Version 1)

• Research type

  Research Study

• Full title

  Safety and efficacy study comparing a new hMG formulation (hMG-IBSA) to a reference product (Menopur®) in patients undergoing ovarian stimulation for in vitro fertilisation (IVF)

• IRAS ID

  63107

• Contact name

  Gillian Lockwood

• Sponsor organisation

  IBSA Institut Biochimique SA

• Eudract number

  2010-021021-13

• ISRCTN Number

  N/A

• Research summary

  The purpose of the study is to evaluate the efficacy and the safety of a new subcutaneous hMG preparations (hMG-IBSA, IBSA Institut Biochimique SA) as compared with an existing formulation (Menopur©, Ferring Pharmaceuticals) when administered to patients undergoing controlled ovariantstimulation for IVF.

• REC name

  South Central - Oxford B Research Ethics Committee

• REC reference

  10/H0605/63

• Date of REC Opinion

  25 Nov 2010

• REC opinion

  Further Information Favourable Opinion